AFAR^™ is a medical device company headquartered in Singapore responsible for developing a series of revolutionary wound care, OTC and cosmetic products. The Team focuses on innovative R&D, aggressive patenting and licensing of our technology to larger industry participants with appropriate distribution, sales, and marketing. The Team works to make it as easy as possible to license the technology by partnering with first class manufacturers, undertaking clinical trials and completing regulatory approvals. To date, AFAR^™ have received HSA (Singapore), CE (Europe), ANVISA (Brazil) and TGA (Australia) regulatory approvals and been awarded one patent from the UPTO with patents filed on all other products.